(iv) The use of bone morphogenetic proteins (BMPs) in long-bone non-unions

Current Orthopaedics

Volumn 21, Issue 4, 2007, Pages 268-279

  Dinopoulos, Haralampos ^a   Giannoudis, Peter V ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Bone morphogenetic proteins (BMPs); Long bone non unions; Osteogenic protein 1 (OP 1); Recombinant (rh)BMP 2 and rh BMP 7

Indexed keywords

RECOMBINANT OSTEOGENIC PROTEIN 1;

ADD ON THERAPY; ARTICLE; BONE DEFECT; BONE GRAFT; BONE TISSUE; CLINICAL STUDY; CLINICAL TRIAL; DONOR SITE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FRACTURE NONUNION; FRACTURE REDUCTION; GENETIC ENGINEERING; GRAFT RECIPIENT; HUMAN; IMPLANT; INFECTION RISK; LONG BONE; NONHUMAN; OPEN FRACTURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TIBIA FRACTURE; TREATMENT RESPONSE;

EID: 34848922118     PISSN: 02680890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cuor.2007.07.007     Document Type: Article

References (115)

1. Praemer A., Furner S., and Rice D.P. Musculoskeletal injuries. Musculoskeletal conditions in the United States (1992), American Academy of Orthopaedic Surgeons, Park Ridge, IL 85-124
2. Heckman J.D., and Sarasohn-Kahn J. The economics of treating tibia fractures: the cost of delayed unions. Bull Hosp Jt Dis 56 1 (1997) 63-72
3. Saleh K, et al. Socioeconomic burden of traumatic tibial fractures: nonunion or delayed union CME. 〈http://www.medscape.com/viewprogram/625_pnt〉.
4. Brinker M.R. Nonunions: evaluation and treatment. In: Browner B.D., Jupiter J.B., Levine A.M., and Trafton P.G. (Eds). Skeletal trauma basic science management and reconstruction. 3rd ed vol. 1 (2003), Saunders, Philadelphia 507-604
5. Paley D., Catagni M.A., Argnani F., et al. Ilizarov treatment of tibial nonunions with bone loss. Clin Orthop 241 (1989) 146-165
6. Weber B.G., and Cech O. Pseudoarthrosis: pathology, biomechanics, therapy, results (1976), Hans Huber Medical Publisher, Berne, Switzerland
7. Wiss D.A., and Stetson W.B. Tibial nonunion: treatment alternatives. J Am Acad Orthop Surg 4 5 (1996) 249-257
8. Sorger J.I., Hornicek F.J., Zavatta M., Menzner J.P., Gebhardt M.C., Tomford W.W., et al. Allograft fractures revisited. Clin Orthop Relat Res 382 (2001) 66-74
9. Suedkamp N.P., Barbey N., Veuskens A., Tempka A., Haas N.P., Hoffmann R., et al. The incidence of osteitis in open fractures: an analysis of 948 open fractures (a review of the Hannover experience). J Orthop Trauma 7 (1993) 473-482
10. Arrington E.D., Smith W.J., Chambers H.G., Bucknell A.L., and Davino N.A. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 329 (1996) 300-309
11. Banwart J.C., Asher M.A., and Hassanein R.S. Iliac crest bone graft harvest donor site morbidity. Spine 20 9 (1995) 1055-1060
12. Fernyhough J.C., Schimandle J.J., Weigel M.C., Edwards C.C., and Levine A.A. Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion. Spine 17 210 (1992) 1474-1480
13. Lietman S.A., Tomford W.W., Gebhardt M.C., Springfield D.S., and Mankin H.J. Complications of irradiated allografts in orthopaedic tumor surgery. Clin Orthop Relat Res 375 (2000) 214-217
14. Seiler III J.G., and Johnson J. Iliac crest autogenous bone grafting: donor site complications. J South Orthop Assoc 9 (2000) 91-97
15. Bauer T.W., and Muschler G.F. Bone graft materials. An overview of the basic science. Clin Orthop 371 (2000) 10-27
16. Brighton C.T. The treatment of non-unions with electricity. J Bone Joint Surg Am 63 5 (1981) 847-851
17. Brighton C.T., Friedenberg Z.B., Zemsky L.M., and Pollis P.R. Direct current stimulation of non-union and congenital pseudarthrosis. Exploration of its clinical application. J Bone Joint Surg Am 57 3 (1975) 368-377
18. Connolly J.F., Guse R., Tiedeman J., and Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 266 (1991) 259-270
19. Garg N.K., Gaur S., and Sharma S. Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture. Acta Orthop Scand 64 6 (1993) 671-672
20. Healey J.H., Zimmerman A.B., McDonnell J.M., and Lane J.M. Percutaneous bone marrow grafting of delayed union and non-union in cancer patients. Clin Orthop 256 (1990) 280-285
21. Mayr E., Frankel V., and Ruter A. Ultrasound-an alternative healing method for nonunions?. Arch Orthop Trauma Surg 120 1-2 (2000) 1-8
22. Moucha C.S., and Einhorn T.A. Enhancement of skeletal repair. In: Browner B.D., Jupiter J.B., Levine A.M., and Trafton P.G. (Eds). Skeletal trauma basic science management and reconstruction. 3rd ed vol. 1 (2003), Saunders, Philadelphia 639-660
23. Nolte P.A., van der Krans A., Patka P., et al. Low-intensity pulsed ultrasound in the treatment of non-unions. J Trauma 51 4 (2001) 693-702
24. Paterson D.C., Lewis G.N., and Cass C.A. Treatment of delayed union and nonunion with an implanted direct current stimulator. Clin Orthop 148 (1980) 117-128
25. Reckling F.W., et al. Treatment of non-unions of fractures of the tibial diaphysis by posterolateral cortical cancellous bone-grafting. J Bone Joint Surg 62-A (1980) 936-941
26. Schaden W., Fischer A., and Sailler A. Extracorporeal shock wave therapy of nonunion or delayed osseous union. Clin Orthop 387 (2001) 90-94
27. Scranton P.E. Use of bone graft substitutes in lower extremity reconstructive surgery. Foot Ankle Int 23 8 (2002) 689-692
28. Shors E.C. Coralline bone graft substitutes. Ortho Clinics North Am 30 4 (1999) 599-613
29. Wilkins R.M., Chimenti B.T., and Rifkin R.M. Percutaneous treatment of long bone nonunions: the use of autologous bone marrow and allograft bone matrix. Orthopedics 26 Suppl. 5 (2003) s549-s554
30. Friedlaender G.E., Perry C.R., Cole J.D., Cook S.D., Cierny G., Muschler G.F., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83 Suppl. 1 (2001) S151-S158
31. Johnson E.E., Urist M.R., and Finerman G.A. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin Orthop 230 (1988) 257-265
32. Jimenez ML, Anderson TL. The use of allograft, platelet derived growth factors, and internal bone stimulation for treatment of recalcitrant nonunions. In: OTA 19th annual meeting; 2003 [abstract].
33. McKee MD, Schemitsch EH, Waddell JP, Kreder HJ, Stephen DJG, Leighton RK, the Canadian Orthopaedic Trauma Society, et al. The effect of human recombinant bone morphogenic protein (rh-BMP-7) on the healing of open tibial shaft fractures: results of a multi-center, prospective, randomized clinical trial. In: Proceedings of the 18th annual meeting of the Orthopaedic Trauma Association; Toronto, Ontario, Canada; October 11-13; 2002. p. 157-8.
34. Ozkaynak E., Rueger D.C., Drier E.A., et al. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 9 7 (1990) 2085-2093
35. Urist M. Bone formation by autoinduction. Science 12 150(698) (1965) 893-899
36. Harwood P.J., and Giannoudis P.V. Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects. Expert Opin Drug Saf 4 1 (2005) 75-89
37. Chen D., Zhao M., and Mundy G.R. Bone morphogenetic proteins. Growth Factors 22 (2004) 233-241
38. Matthews S.J.E. Biological activity of bone morphogenetic proteins (BMP's). Injury, Int J Care Injured 36S (2005) S34-S37
39. Rutheford R.B., Gu K., Racenis P., and Krebsbach P.H. Early events: the in vitro conversion of BMP transduced fibroblasts to chondroblasts. Connect Tissue Res 44 Suppl. 1 (2003) 117-123
40. Reddi A.H. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 83 Suppl. 1 Pt 7 (2001) S1-S6
41. Mont M.A., Ragland P.S., Biggins B., Friedlaender G., Patel T., Cook S., et al. Use of bone morphogenetic proteins for musculoskeletal applications. An overview. J Bone Joint Surg Am 86 Suppl. 2 (2004) 41-55
42. Sakou T. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22 (1998) 591-603
43. Wozney J.M., and Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 346 (1998) 26-37
44. Meyer R.A., Meyer M.H., Pheiffer L.S., and Banks D.M. Delayed union of femoral fractures in older rats: decreased gene expression. BMC Musculoskelet Disord 2 (2001) 2
45. Kloen P., Doty S.B., Gordon E., Rubel I.F., Goumans M.J., and Helfet D.L. Expression and activation of the BMP-signaling components in human fracture nonunions. J Bone Joint Surg Am 84 (2002) 1909-1918
46. Hollinger J.O., and Kleinschmidt J.C. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg 1 (1990) 60-68
47. In: Proceedings of the international conference on bone morphogenetic proteins; Lake Tahoe, CA. June 7-11; 2000. J Bone Joint Surg Am 2001;83(Suppl. 1) (Pt 1).
48. Takagi K., and Urist M.R. The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. Clin Orthop 171 (1982) 224-231
49. Nilsson O.S., Urist M.R., Dawson E.G., Schmalzried T.P., and Finerman G.A. Bone repair induced by bone morphogenetic protein in ulnar defects in dogs. J Bone Joint Surg Br 68 (1986) 635-642
50. Heckman J.D., Boyan B.D., Aufdemorte T.B., and Abbott J.T. The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg 73-A 5 (1991) 750-764
51. Yasko A.W., Lane J.M., Fellinger E.J., Rosen V., Wozney J.M., and Wang E.A. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 74 (1992) 659-670
52. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., Rueger D.C., and Whitecloud T.S. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg 76-A 6 (1994) 827-838
53. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., and Rueger D.C. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop 301 (1994) 302-312
54. Cook S.D., Wolf M.W., Salkeld S.L., and Rueger D.C. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 77 (1995) 734-750
55. Boström M., Lane J.M., Tomin E., Browne M., Berberian W., Turek T., et al. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop 327 (1996) 272-282
56. Gao T.J., Lindholm T.S., Kommonen B., Ragni A., Paronzini A., Lindholm T.C., et al. Enhanced healing of segmental tibial defects in sheep by a composite bone substitute composed of tricalcium phosphate cylinder, bone morphogenetic protein, and type IV collagen. J Biomed Mater Res 32 (1996) 505-512
57. Gao T.J., Lindholm T.S., Kommonen B., Ragni P., Paronzini A., Lindholm T.C., et al. The use of coral composite implant containing bone morphogenetic protein to repair a segmental tibial defect in sheep. Int Orthop 21 (1997) 194-200
58. Sciadini M.F., Dawson J.M., and Johnson K.D. Bovine-derived bone protein as a bone graft substitute in a canine segmental defect model. J Orthop Trauma 11 7 (1997) 496-508
59. Sciadini M.F., Dawson J.M., and Johnson K.D. Evaluation of bovine-derived bone protein with a natural coral carrier as a bone-graft substitute in a canine segmental defect model. J Orthop Res 15 (1997) 844-857
60. Zegzula H.D., Buck D.C., Brekke J., Wozney J.M., and Hollinger J.O. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 79 (1997) 1778-1790
61. Zellin G., and Linde A. Treatment of segmental defects in long bones using osteopromotive membranes and recombinant human bone morphogenetic protein-2. An experimental study in rabbits. Scand J Plast Reconstr Hand Surg 31 2 (1997) 97-104
62. Itoh T., Mochizuki M., Nishimura R., Matsunaga S., Kadosawa T., Kokubo S., et al. Repair of ulnar segmental defect by recombinant human bone morphogenetic protein-2 in dogs. J Vet Med Sci 60 4 (1998) 451-458
63. Cook S.D., Salkeld S.L., Brinker M.R., Wolfe M.W., and Rueger D.C. Use of an osteoinductive biomaterial (rhOP-1) in healing large segmental bone defects. J Orthop Trauma 12 6 (1998) 407-412
64. Kirker-Head C.A., Gerhart T.N., Armstrong R., Schelling S.H., and Carmel L.A. Healing bone using recombinant human bone morphogenetic protein 2 and copolymer. Clin Orthop 349 (1998) 205-217
65. Lane J.M., Yasko A.W., Tomin E., Cole B.J., Waller S., Browne M., et al. Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. Clin Orthop 361 (1999) 216-227
66. Teixeira J.O., and Urist M.R. Bone morphogenetic protein induced repair of compartmentalized segmental diaphyseal defects. Arch Orthop Trauma Surg 117 2 (1998) 27-34
67. Wheeler D.L., Chamberland D.L., Schmitt J.M., Buck D.C., Brekke J.H., Hollinger J.O., et al. Radiomorphometry and biomechanical assessment of recombinant human bone morphogenetic protein 2 and polymer in rabbit radius osteotomy model. J Biomed Mater Res 43 4 (1998) 365-373
68. Heckman J.D., Ehler W., Brooks B.P., Aufdemorte T.B., Lohmann C.H., Morgan T., et al. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal non-unions implanted with a biodegradable composite polymer. J Bone Joint Surg 81-A 12 (1999) 1717-1729
69. Isobe M., Yamazaki Y., Mori M., and Amagasa T. Bone regeneration produced in rat femur by polymer capsules containing recombinant human bone morphogenetic protein-2. J Oral Maxillofac Surg 57 (1999) 695-698
70. Ohura K., Hamanishi C., Tanaka S., and Matsuda N. Healing of segmental bone defects in rats induced by a beta-TCP-MCPM cement combined with rh-BMP-2. J Biomed Mater Res 44 2 (1999) 168-175
71. Sciadini M.F., and Johnson K.D. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model. J Orthop Res 18 (2000) 289-302
72. Betz O.B., Betz V.M., Nazarian A., Pilapil C.G., Vrahas M.S., Bouxsein M.L., et al. Direct percutaneous gene delivery to enhance healing of segmental bone defects. J Bone Joint Surg Am 88 (2006) 355-365
73. Boden S.D., Zdeblick T.A., Sandhu H.S., and Heim S.E. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25 (2000) 376-381
74. Einhorn T.A. Clinical applications of recombinant human BMPs: early experience and future development. J Bone Joint Surg Am 85 Suppl. 3 (2003) 82-88
75. Ronga M., Baldo F., Zappala G., and Cherubino P. Recombinant human bone morphogenetic protein-7 for treatment of long bone nonunion: an observational, retrospective, non-randomized study of 105 patients. Injury, Int J Care Injured 37S (2006) S51-S56
76. Talwar R., Di Silvio L., Hughes F.J., and King G.N. Effects of carrier release kinetics on bone morphogenetic protein-2-induced periodontal regeneration in vivo. J Clin Periodontol 28 (2001) 340-347
77. Uludag H., Gao T., Porter T.J., Friess W., and Wozney J.M. Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Joint Surg Am 83 Suppl. 1 Pt 2 (2001) S128-S135
78. Alt V., and Heissel A. Economic considerations for the use of recombinant human bone morphogenetic protein-2 in open tibial fractures in Europe: the German model. Curr Med Res Opin 22 Suppl. 1 (2006) 19-22
79. den Boer F.C., Wippermann B.W., Blokhuis T.J., Patka P., Bakker F.C., and Haarman H.J. Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow. J Orthop Res 21 (2003) 521-528
80. Gerhart T.N., Kirker-Head C.A., Kriz M.J., Holtrop M.E., Hennig G.E., Hipp J., et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop Relat Res 293 (1993) 317-326
81. Einhorn T.A., Majeska R.J., Mohaideen A., Kagel E.M., Bouxsein M.L., Turek T.J., et al. A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair. J Bone Joint Surg Am 85 (2003) 1425-1435
82. Johnson E.E., Urist M.R., and Finerman G.A. Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP). Clin Orthop 250 (1990) 234-240
83. Johnson E.E., et al. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion. Clin Orthop Relat Res 371 (2000) 61-74
84. Geesink R.G., Hoefnagels N.H., and Bulstra S.K. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 81 (1999) 710-718
85. McKee MD, Waddell JP, Wild L. The treatment of long bone nonunion with rh BMP: results of a prospective pilot study. In: Poster presentation #242, 71st AAOS meeting, March 10-14, 2004.
86. Susarla A, Tejwani NC, Koval KJ, Egol KA. OP 1 implant as an adjunct to mechanical fixation in humeral non-union. In: Poster presentation #241, AAOS meeting, March 10-14, 2004.
87. Dimitriou R., Dahabreh Z., Katsoulis E., Matthews J., Branfoot T., and Giannoudis P.V. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury, Int J Care Injured 36S (2005) S51-S59
88. Giannoudis P.V., and Tzioupis C. Clinical applications of BMP-7. The UK perspective. Injury, Int J Care Injured 36S (2005) S47-S50
89. Jones A.L., et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 88 7 (2006) 1431-1441
90. Johnsson R., Stromqvist B., and Aspenberg P. Randomized radiostereometric study comparing osteogenic progrien-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion. Spine 27 (2002) 2654-2661
91. Johnson E.E., Urist M.R., and Finerman G.A. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. Clin Orthop Relat Res 236 (1988) 249-257
92. Johnson E.E., et al. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. Clin Orthop 236 (1988) 249-257
93. Riedel G.E., and Valentin-Opran A. Clinical evaluation of rh-BMP-2/ACS in orthopedic trauma: a progress report. Orthopedics 22 (1999) 663-665
94. Govender S., Csimma C., Genant H.K., Valentin-Opran A., Amirt V., Arbel R., et al. BMP-2 evaluation in surgery for tibial trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84 (2002) 2123-2134
95. Miniscalco P., et al. Healing of fresh tibial fractures with OP-1. A preliminary report. Acta Bio-Medica 73 1-2 (2002) 27-33
96. Ripamonti U., Van Den Heever B., Sampath T.K., Tucker M.M., Rueger D.C., and Reddi A.H. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 13 (1996) 273-289
97. Valentin-Opran A., Wozney J., Csimma C., Lilly L., and Riedel G.E. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res 395 (2002) 110-120
98. Canalis E., Economides A.N., and Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24 (2003) 218-235
99. Itoh K., Udagawa N., Katagiri T., Iemura S., Ueno N., Yasuda H., et al. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 142 (2001) 3656-3662
100. Udagawa N. Mechanisms involved in bone resorption. Biogerontology 3 (2002) 79-83
101. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F., et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267 (1992) 20352-20362
102. Sandhu H.S. Bone morphogenetic proteins and spinal surgery. Spine 28 (2003) S64-S73
103. Sandhu H.S., Kanim L.E., Kabo J.M., Toth J.M., Zeegen E.N., Liu D., et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 21 (1996) 2115-2122
104. Glaser D.L., Economides A.N., Wang L., Liu X., Kimble R.D., Fandl J.P., et al. In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am 85 (2003) 2332-2342
105. Termaat M.F., Den Boer F.C., Bakker F.C., Patka P., and Haarman H.J. Bone morphogenetic proteins development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am 87 (2005) 1367-1378
106. New humanitarian device approval, OP-1TM-H010002. Web reference: 〈http://www.fda.gov/cdrh/mda/docs/h010002.html〉.
107. Goel A., Sangwan S.S., Siwach R.C., and Ali A.M. Percutaneous bone marrow grafting for the treatment of tibial non-union. Injury 36 1 (2005) 203-206
108. Jean J.-L., Tang H.-L., Wang S.-J., Chang J.-H., Lin S.-C., Chen C.-J., et al. Efficacy of autologous percutaneous bone marrow graft injection for treatment of nonunion of the tibia. Formosan J Surg 34 6 (2001) 294-301
109. Matsuda Y., Sakayama K., Okumura H., Kawatani Y., Mashima N., and Shibata T. Percutaneous autologous bone marrow transplantation for nonunion of the femur. Nippon Geka Hokan 67 1 (1998) 10-18
110. Pan K.L., Shukur M.H., Ghani M.A.N., and Pan K.L. The role of bone marrow grafts in tibial nonunions. J Orthop Surg (Hong Kong) 4 2 (1996) 47-51
111. Sim R., Liang T.S., and Tay B.K. Autologous marrow injection in the treatment of delayed and non-union in long bones. Singapore Med J 34 5 (1993) 412-417
112. Siwach R.C., Sangwan S.S., Singh R., and Goel A. Role of percutaneous bone marrow grafting in delayed unions, non-unions and poor regenerates. Indian J Med Sci 55 6 (2001) 326-336
113. Wang L., Li W.S., and Zhang Q.S. Autogenous bone marrow graft for the management of nonunion of tibia. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 15 1 (2001) 24-25
114. Schmitt J.M., Hwang K., Winn S.R., and Hollinger J.O. Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res 17 (1999) 269-278
115. Food and Drug Administration (FDA). OP-1 implant. Summary of safety and probable benefit. Available from 〈http://www.fda.gov/cdrh/pdf/h010002b.pdf〉.